课题基金 / 基金详情

Functional Interaction of Amyloid-b Protein with Glial Toll-Like Receptors

Functional Interaction of Amyloid-b Protein with Glial Toll-Like Receptors
淀粉样蛋白-b 与神经胶质 Toll 样受体的功能相互作用
批准号:
8101760
负责人:
Michael R. Nichols
金额:
$36.31万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2015-03-31

项目摘要

项目成果

Michael R. Nichols的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is a progressive neurodegenerative illness characterized by increasing dementia and ultimately death. Outstanding pathological features of AD include severe neuronal loss, accumulation of aggregated amyloid-¿ protein (A¿) in senile plaques and diffuse deposits, and neurofibrillary tau tangles. It is generally agreed that A¿ accumulation is a primary cause of AD yet several central questions remain. 1) What A¿ structure, aggregation state or species contributes to AD? and 2) How does the human immune system recognize and respond to A¿? Significant data demonstrate a sustained inflammatory response to A¿ in the AD brain which includes clustering of activated microglia and cytokines around A¿ deposits. Surprisingly, not all A¿ deposits provoke an inflammatory response suggesting that A¿ morphology/structure influences the response. These results raise several puzzling questions regarding the mechanism by which A¿ provokes an inflammatory response. Recent work has established that Toll-like receptors (TLRs) of the innate immune system mediate a proinflammatory response to aggregated A¿ suggesting that A¿ may possess structural elements that are similar to microbial macromolecules. The work in this proposal will utilize biophysical and cellular studies to establish a connection between A¿ morphology/structure and inflammation in primary murine microglia and astrocytes. The first research aim will investigate a variety of conditions that influence A¿ aggregation and structure and identify the conditions that result in the greatest A¿ proinflammatory activity (cytokine production) in primary microglia and astrocytes. A variety of biophysical techniques will be used to further understand the connection between A¿ structure and glial activation. The second research aim will utilize normal and transgenic knockout mice to identify and characterize complexes of TLRs, co-receptors, and protein cofactors that mediate A¿ bioactivity at the glial cell surface and inside the cell. Further understanding of A¿ activity may help explain why the human immune system is ineffective at controlling AD and provide a legitimate point of therapeutic mitigation. The scientific and biomedical importance of this project is its direct contribution to the understanding of Alzheimer's disease. The additional and equally important aspect of the project is the training opportunities that it provides for graduate and undergraduate researchers. The proposed research, which is a blend of cell biology, biochemistry, biophysics, nanoscience, and spectroscopy, will attract a diverse group of students to participate in interdisciplinary studies. This broad range of science will promote collaborative work and interactions between students and faculty from different departments. The primary mission of the project is to make a significant impact on Alzheimer's disease. An equally important objective is to prepare students for future interdisciplinary research by gaining knowledge in a multiple research areas, learning and refining laboratory skills, and interpreting, presenting, and publishing meaningful results. PUBLIC HEALTH RELEVANCE: Deaths from Alzheimer's disease (AD) have increased by 45% from 2000 to 2005, while deaths from heart disease, breast cancer, prostate cancer, and stroke have declined during the same time period. AD is projected to reach epic proportions by the middle of the 21st century overwhelming medical resources. The most appropriate way to develop treatments that will prevent or treat AD is to understand the underlying biochemical features of the disease. This proposal will examine molecular mechanisms linking AD and the human immune response potentially leading to therapies that utilize our own immune system to fight AD. Furthermore, the project will incorporate rigorous research training of students at all levels that will ultimately have a positive long-term impact on public health.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.abb.2016.03.017
发表时间: 2016-05-01
期刊: Archives of biochemistry and biophysics
影响因子: 3.9
作者: [Terrill-Usery SE, Colvin BA, Davenport RE, Nichols MR]
通讯作者: Nichols MR
DOI: 10.1007/s11481-012-9424-6
发表时间: 2013-03
期刊: JOURNAL OF NEUROIMMUNE PHARMACOLOGY
影响因子: 6.2
作者: [Paranjape, Geeta S., Terrill, Shana E., Gouwens, Lisa K., Ruck, Benjamin M., Nichols, Michael R.]
通讯作者: Nichols, Michael R.
DOI: 10.1016/j.brainres.2016.08.016
发表时间: 2016-10-01
期刊: Brain research
影响因子: 2.9
作者: [Gouwens LK, Makoni NJ, Rogers VA, Nichols MR]
通讯作者: Nichols MR
Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia.
尽管小胶质细胞中细胞内 IL-1β 积累显着,但淀粉样蛋白-β(1-42) 原纤维仍会刺激大量分泌的 IL-1β。
DOI: 10.1016/j.bbadis.2014.08.001
发表时间: 2014-11
期刊: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
影响因子: 6.2
作者: [Terrill-Usery, Shana E., Mohan, Michael J., Nichols, Michael R.]
通讯作者: Nichols, Michael R.
Mechanisms of NLRP3 inflammasome activation
  • 批准号:
    10796165
  • 项目类别:
  • 资助金额:
    $45.93万
  • 财政年份:
    2023
  • 负责人:
    Michael R. Nichols
  • 依托单位:
Oligomerization State and Function of the NLRP3 Inflammasome
  • 批准号:
    9099379
  • 项目类别:
  • 资助金额:
    $43.95万
  • 财政年份:
    2016
  • 负责人:
    Michael R. Nichols
  • 依托单位:
海外基金